20-F/A

AMENDMENT NO. 1 TO FORM 20-F

Company: Quoin Pharmaceuticals, Ltd.
Filed: August 4, 2020
Period of Report: December 31, 2019
Accession Number: 0001213900-20-020139

View Document ↗ View on SEC.gov ↗